SKF 97574

Drug Profile

SKF 97574

Alternative Names: B9937-051; BY 574

Latest Information Update: 21 Jan 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Developer ALTANA Pharma; GlaxoSmithKline
  • Class Antiulcers; Gastric antisecretories
  • Mechanism of Action Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Peptic ulcer

Most Recent Events

  • 21 Jan 2008 Discontinued for Peptic ulcer in Germany (unspecified route)
  • 16 Dec 1999 No-Development-Reported for Peptic ulcer in Germany (Unknown route)
  • 14 Oct 1994 Discontinued-I for Peptic ulcer in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top